Publicacions Dermatologia

Any 2024

Articles:

• Acral melanoma in the Caucasian population: a comprehensive cohort study on epidemiological, clinicopathological, and prognostic features. Angel-Baldo J, Podlipnik S, Azón A, Boada A, Arrieta A, Marcoval J, López-Sánchez C, Sàbat M, Segura S, Bodet D, Curcó N, Lopez-Castillo D, Solà J, Quintana-Codina M, Baliu-Piqué C, Just-Sarobé M, Mar-tín-Sala S, Malvehy J, Puig S, Carrera C, Marti RM; Network of Melanoma Centers in Catalonia.Actas Dermosifiliogr. 2025 Mar 3:S0001-7310(25)00111-5. doi: 10.1016/j.ad.2025.02.023. Online ahead of print.

• No tuberculosis reactivations in psoriasis patients initiating new generation biologics de-spite untreated latent tuberculosis infection: Multicenter case series of 35 patients Nerea Manzanares 1, Eva Vilarrasa 2, Anna López 2, Maria Luisa Alonso 3, Manel Velasco 4, Josep Rie-ra 5, Elena Del Alcázar 6, José Manuel Carrascosa 6, Antoni Azón 7, Raquel Rivera 8, Sergio San-tos 9, Laura Salgado-Boquete 10, Mónica Roncero 11, Maria Dorado 12, Oriol Yelamos 13, Carmen Delga-do 14, Fernando Gallardo 1, Marta Ferran 1 J Eur Acad Dermatol Venereol. 2024 Jan;38(1):e26-e28. doi: 10.1111/jdv.19406. Epub 2023 Aug 25.

• Dupilumab treatment in paediatric atopic dermatitis (2-18 years): Spanish multicentre retrospec-tive real-world study. Iznardo H, Roé E, Vicente A, Prat C, Casals M, Martín-Santiago A, Esteve A, Viñas M, Munera-Campos M, Corella F, Mollet J, Figueras-Nart I, Vila A, Soria X, Azón-Masoliver A, Marqués-Martín L, Nadal-Lladó C, Bel S, Pujol-Montcusí J, Bertolín-Colilla M, Curto-Barredo L, Melé-Ninot G, Evole M, Berbegal L, Puig L, Baselga E. Clin Exp Dermatol. 2024 Dec 23;50(1):104-112. doi: 10.1093/ced/llae300.PMID: 39093288

• Parental Assessment of Infantile Hemangioma Cosmetic Clinical Outcomes: Results of the Spanish Hemangioma Nationwide Prospective Cohort M Colmenero-Sendra 1, J Del Boz-González 2, E Baselga Torres 3, J Bernabéu-Wittel 4, E Roé-Crespo 5, A Vicente 6, M Valdivieso-Ramos 7, A Martín-Santiago 8, S I Palencia-Pérez 9, M T Montserrat-García 4, A Azón-Masoliver 10, M Dañino 11, C Tubau Prims 5, C Prat 6, A Giacaman 8, J J Domínguez-Cruz 4, A Bau-zá Alonso 8, M Grau-Pérez 12, M Á Descalzo 13, I García-Doval 14 Actas Dermosifiliogr. 2024 Dec 4:S0001-7310(24)00913-X.doi: 10.1016/j.ad.2024.11.023.

• Baniandrés O, Balaguer Franch I, Vilarrasa Rull E, Imbernón Moya A, Alonso Pacheco ML, Mateu Puchades A, Hergueta Sánchez JP, Mataix Díaz FJ, Ballano Ruiz A, González Cantero Á, Martínez Lorenzo E, Galán Gutiérrez M, Rodríguez Fernández-Freire L, Vila Payeras A, Muñoz Santos C, Hernández Bel P, Hernández Ostiz S, Pujol Montcusí J, Álvarez Salafranca M, Coto Segura P, Martínez Pallas I, Azón Masoliver A, Martínez Manchón T, Delgado Mucientes C, Schneller-Pavelescu Apetrei CL, Ballester Martínez A, Monte Serrano J, Pindado Ortega C, Reguero Del Cura L, López Barragán I, Chavarría Mur E, González Olivares M, de la Cueva Dobao P. Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real-Life Cohort and Literature Review. Int J Dermatol. 2025 Sep 10. doi: 10.1111/ijd.70053. Epub ahead of print. PMID: 40931458.

• Planella-Fontanillas N, Bosch-Amate X, Jiménez Antón A, Moreno-Vílchez C, Guerrero MG, Blanes Martínez MDM, Ballester Martínez MA, Bassas-Freixas P, Castaño Fernández JL, Estébanez Corrales A, Suarez Fernández R, Santos Alarcón S, Alonso AB, Torrent M, Ballano Ruiz A, Collantes Rodríguez C, España A, Fonseca Capdevila E, Faure IG, Hernández Fernández CP, Melgosa Ramos FJ, Spertino J, Zaragoza Ninet V, Armillas L, Bielsa I, Carrera C, Esquius Rafat M, Fulgencio Barbarin J, Fernandez Vela J, Lova Navarro M, Martín Callizo C, Martín-Sala S, Ojeda R, Amer MEP, Puigdollers AS, Pujol RM, Podlipnik S, Mascaró JM Jr, Curto-Barredo L. Real-world evaluation of the effectiveness and safety of dupilumab in bullous pemphigoid: an ambispective multicentre case series. Br J Dermatol. 2025 Feb 18;192(3):501-509. doi: 10.1093/bjd/ljae403. PMID: 39418120.